HedgePath Pharmaceuticals Announces Notice of Allowability of US Patent Application Regarding Treatment of Prostate Cancer – PRNewswire

HedgePath Pharmaceuticals Announces Notice of Allowability of US Patent Application Regarding Treatment of Prostate Cancer  PRNewswire

Patent expected to issue coincident with HedgePath’s 2019 efforts to clear IND for SUBA®-Itraconazole for the treatment of prostate cancer …